| Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features M Zuberi, R Mir, J Das, I Ahmad, J Javid, P Yadav, M Masroor, S Ahmad, ... Clinical and Translational Oncology 17, 779-787, 2015 | 150 | 2015 |
| Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients P Yadav, M Mirza, K Nandi, SK Jain, RCM Kaza, N Khurana, PC Ray, ... Tumor Biology 37, 15275-15282, 2016 | 43 | 2016 |
| Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus M Alfaifi, MMA Beg, MY Alshahrani, I Ahmad, AG Alkhathami, PC Joshi, ... BMJ Open Diabetes Research and Care 9 (1), e001821, 2021 | 35 | 2021 |
| Simple multiplex RT-PCR for identifying common fusion BCR-ABL transcript types and evaluation of molecular response of the a2b2 and a2b3 transcripts to Imatinib resistance in … R Mir, I Ahmad, J Javid, M Zuberi, P Yadav, R Shazia, M Masroor, S Guru, ... Indian journal of cancer 52 (3), 314-318, 2015 | 33 | 2015 |
| Expression analysis of serum microRNA-34a and microRNA-183 in hepatocellular carcinoma D Bharali, HB Jebur, D Baishya, S Kumar, MP Sarma, M Masroor, J Akhter, ... Asian Pacific journal of cancer prevention: APJCP 19 (9), 2561, 2018 | 27 | 2018 |
| Association of rheumatoid arthritis with diabetic comorbidity: correlating accelerated insulin resistance to inflammatory responses in patients AK Verma, D Bhatt, Y Goyal, K Dev, MMA Beg, MA Alsahli, AH Rahmani Journal of Multidisciplinary Healthcare, 809-820, 2021 | 26 | 2021 |
| Assessment of cell-free long non-coding RNA-H19 and miRNA-29a, miRNA-29b expression and severity of diabetes M Alfaifi, AK Verma, MY Alshahrani, PC Joshi, AG Alkhathami, I Ahmad, ... Diabetes, Metabolic Syndrome and Obesity, 3727-3737, 2020 | 24 | 2020 |
| The promising signatures of circulating microRNA-145 in epithelial ovarian cancer patients M Zuberi, R Mir, I Khan, J Javid, SA Guru, M Bhat, MP Sumi, I Ahmad, ... MicroRNA 9 (1), 49-57, 2020 | 23 | 2020 |
| Promoter methylation of BRCA1, DAPK1 and RASSF1A is associated with increased mortality among indian women with breast cancer P Yadav, M Masroor, K Nandi, RCM Kaza, SK Jain, N Khurana, A Saxena Asian Pacific Journal of Cancer Prevention: APJCP 19 (2), 443, 2018 | 22 | 2018 |
| NLRP3 inflammasome in rosmarinic acid-afforded attenuation of acute kidney injury in mice J Akhter, J Khan, M Baghel, MMA Beg, P Goswami, MA Afjal, S Ahmad, ... Scientific reports 12 (1), 1313, 2022 | 18 | 2022 |
| Assessment and management of diabetic patients during the COVID-19 pandemic AK Verma, MMA Beg, D Bhatt, K Dev, MA Alsahli, AH Rahmani, Y Goyal Diabetes, Metabolic Syndrome and Obesity, 3131-3146, 2021 | 18 | 2021 |
| RASSF1 and PTEN promoter hypermethylation influences the outcome in epithelial ovarian cancer M Zuberi, R Mir, S Dholariya, I Najar, P Yadav, J Javid, S Guru, M Mirza, ... Clinical Ovarian and Other Gynecologic Cancer 7 (1-2), 33-39, 2014 | 18 | 2014 |
| miR-486-5p: a prognostic biomarker for chronic myeloid leukemia A Suchiita, SA Guru, P Yadav, M Masroor, A Samadhiya, N Bhutani, ... ACS omega 6 (11), 7711-7718, 2021 | 16 | 2021 |
| IgLON5 regulates the adhesion and differentiation of myoblasts JH Lim, MMA Beg, K Ahmad, S Shaikh, SS Ahmad, HJ Chun, D Choi, ... Cells 10 (2), 417, 2021 | 16 | 2021 |
| Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients P Yadav, M Masroor, K Tanwer, R Mir, J Javid, I Ahmad, M Zuberi, ... Clinical and Translational Oncology 18, 728-734, 2016 | 16 | 2016 |
| CC genotype of anti-apoptotic gene BCL-2 (− 938 C/A) is an independent prognostic marker of unfavorable clinical outcome in patients with non-small-cell lung cancer J Javid, R Mir, M Mirza, A Imtiyaz, Y Prasant, Z Mariyam, PK Julka, ... Clinical and Translational Oncology 17, 289-295, 2015 | 16 | 2015 |
| Serum-based lncRNA ANRIL, TUG1, UCA1, and HIT expressions in breast cancer patients AG Alkhathami, A Hadi, M Alfaifi, MY Alshahrani, AK Verma, MMA Beg Disease Markers 2022, 2022 | 15 | 2022 |
| Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs MM Mashraqi, N Chaturvedi, Q Alam, S Alshamrani, MM Bahnass, ... Molecules 26 (3), 582, 2021 | 12 | 2021 |
| Role and significance of circulating biomarkers: miRNA and E2F1 mRNA expression and their association with type-2 diabetic complications MM Ali Beg, AK Verma, M Saleem, F Saud Alreshidi, F Alenazi, H Ahmad, ... International Journal of Endocrinology 2020, 2020 | 12 | 2020 |
| microRNA-21 expression as prognostic and therapeutic response marker in chronic myeloid leukaemia patients MAB Mirza, SA Guru, SM Abdullah, A Rizvi, A Saxena Asian Pacific Journal of Cancer Prevention: APJCP 20 (8), 2379, 2019 | 12 | 2019 |
Dr Rashid MirDepartment of Medical Lab Technology, Prince Fahd Bin Sultan Research chair Faculty of Applied Medical Sciences ,,University of Tabuk, Kingdom of Saudi Arabia,Verified email at ut.edu.sa
